Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6462.5000
8.50
(
0.13
%)
NSE
Nov 20, 2025
15:31 PM
30.42% Gain from 52W Low
Volume:
114.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
09 Nov 2022
6462.50
0.13%
Divi's Labs (HOLD): Disappointing quarter
Hold:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3450
Target
BOB Capital Markets Ltd.
Q2 revenue fell 7% YoY to Rs 18.5bn, weighed down by a decline in custom synthesis business
Divi's Laboratories .. has an
average target
of 6432.50 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
Market closes higher, supported by foreign inflows
Trendlyne Marketwatch |
20 Nov 2025, 04:08PM
Inflation Is near zero. So why Is the RBI not cutting rates?
The Baseline |
20 Nov 2025, 01:04PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022